TW434405B - Process to determine antigen-specific antibodies of the immunoglobulin class M (IgM) and reagents used therein - Google Patents

Process to determine antigen-specific antibodies of the immunoglobulin class M (IgM) and reagents used therein Download PDF

Info

Publication number
TW434405B
TW434405B TW086117602A TW86117602A TW434405B TW 434405 B TW434405 B TW 434405B TW 086117602 A TW086117602 A TW 086117602A TW 86117602 A TW86117602 A TW 86117602A TW 434405 B TW434405 B TW 434405B
Authority
TW
Taiwan
Prior art keywords
antibody
binding
antigen
patent application
binding partner
Prior art date
Application number
TW086117602A
Other languages
English (en)
Chinese (zh)
Inventor
Elke Faatz
Urban Schmitt
Beatus Ofenloch-Haehnle
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of TW434405B publication Critical patent/TW434405B/zh

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/962Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/825Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
TW086117602A 1996-11-29 1997-11-24 Process to determine antigen-specific antibodies of the immunoglobulin class M (IgM) and reagents used therein TW434405B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19649389A DE19649389A1 (de) 1996-11-29 1996-11-29 Antigenspezifischer IgM-Nachweis

Publications (1)

Publication Number Publication Date
TW434405B true TW434405B (en) 2001-05-16

Family

ID=7813066

Family Applications (1)

Application Number Title Priority Date Filing Date
TW086117602A TW434405B (en) 1996-11-29 1997-11-24 Process to determine antigen-specific antibodies of the immunoglobulin class M (IgM) and reagents used therein

Country Status (18)

Country Link
US (1) US6489129B1 (enExample)
EP (1) EP0944832B1 (enExample)
JP (1) JP3958797B2 (enExample)
KR (1) KR20000057315A (enExample)
CN (1) CN1245560A (enExample)
AR (1) AR009638A1 (enExample)
AT (1) ATE204082T1 (enExample)
AU (1) AU720123B2 (enExample)
BR (1) BR9714365A (enExample)
CA (1) CA2272302A1 (enExample)
DE (2) DE19649389A1 (enExample)
ES (1) ES2162347T3 (enExample)
IL (1) IL130112A0 (enExample)
NO (1) NO992579L (enExample)
NZ (1) NZ335754A (enExample)
TW (1) TW434405B (enExample)
WO (1) WO1998023955A2 (enExample)
ZA (1) ZA9710726B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10009503A1 (de) * 2000-02-29 2001-08-30 Roche Diagnostics Gmbh Verfahren zur Immobilisierung von Konjugaten in diagnostischen Tests
US7105311B2 (en) * 2001-05-03 2006-09-12 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US7262019B2 (en) * 2001-05-03 2007-08-28 Immunetics, Inc. System and methods for detection of Bacillus anthracis related analytes in biological fluids
US7387890B2 (en) 2004-12-16 2008-06-17 Chembio Diagnostic Systems, Inc. Immunoassay devices and use thereof
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
DK2112158T3 (da) 2007-04-20 2012-01-23 Hoffmann La Roche Påvisning af primære infektioner med patogener
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
EP3187585A1 (en) 2010-03-25 2017-07-05 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
ES2667425T3 (es) 2011-06-10 2018-05-10 Oregon Health & Science University Glucoproteínas y vectores recombinantes de CMV
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
CN102507932A (zh) * 2011-12-02 2012-06-20 无锡博慧斯生物医药科技有限公司 一种IgM抗体检测试纸条
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
PE20170259A1 (es) 2014-04-02 2017-04-14 Chembio Diagnostic Systems Inc Inmunoensayo que utiliza un conjugado de captura
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3176580A1 (en) 2015-12-01 2017-06-07 Roche Diagnostics GmbH Method for reduction of interferences in immunoassays
CN105759059A (zh) * 2016-04-27 2016-07-13 丹娜(天津)生物科技有限公司 一种检测EV71病毒IgM抗体的免疫检测试剂盒及其制备方法
CN105974111B (zh) * 2016-07-20 2019-07-09 国家纳米科学中心 一种类风湿因子(IgM型)及其他抗原特异性IgM抗体联合检测的方法
CN107656057A (zh) * 2017-09-06 2018-02-02 中国农业科学院兰州兽医研究所 一种用于检测布鲁氏杆菌病IgM抗体的ELISA试剂盒及其应用
CN112585468B (zh) * 2018-09-18 2024-09-24 美国西门子医学诊断股份有限公司 用于寨卡病毒免疫测定的方法和试剂
CN113495141A (zh) * 2020-03-20 2021-10-12 迈克生物股份有限公司 2019新型冠状病毒IgM抗体检测试剂盒
CN119505004A (zh) * 2023-08-22 2025-02-25 重庆艾生斯生物工程有限公司 抗rf的抗体或其功能性片段及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80129A0 (en) * 1986-09-23 1986-12-31 Savyon Diagnostics Ltd Method for the determination of igm and iga immunoglobulins and reagents therefor
DE3705686C2 (de) * 1987-02-23 1995-11-30 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Antikörpern
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
DE3717401A1 (de) * 1987-05-23 1988-12-08 Behringwerke Ag Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aus einer der immunglobulin-klassen a, m, d oder e und dazu geeignetes mittel
FI970301A7 (fi) 1994-07-25 1997-03-24 Roche Diagnostics Gmbh Spesifisen immunoglobuliinin määrittäminen käyttäen useampaa antigeeni a
CN100478352C (zh) * 1994-07-25 2009-04-15 罗切诊断学有限公司 半抗原标记的肽
DE4439452A1 (de) * 1994-11-04 1996-05-09 Boehringer Mannheim Gmbh Antikörperklassenspezifisches Entstörungsreagenz

Also Published As

Publication number Publication date
AU720123B2 (en) 2000-05-25
JP2001506749A (ja) 2001-05-22
CA2272302A1 (en) 1998-06-04
NO992579L (no) 1999-07-28
EP0944832A2 (de) 1999-09-29
WO1998023955A3 (de) 1998-07-23
EP0944832B1 (de) 2001-08-08
JP3958797B2 (ja) 2007-08-15
ZA9710726B (en) 1999-05-28
KR20000057315A (ko) 2000-09-15
DE19649389A1 (de) 1998-06-04
DE59704261D1 (de) 2001-09-13
NZ335754A (en) 2001-05-25
ES2162347T3 (es) 2001-12-16
AU5751398A (en) 1998-06-22
NO992579D0 (no) 1999-05-28
CN1245560A (zh) 2000-02-23
US6489129B1 (en) 2002-12-03
IL130112A0 (en) 2000-06-01
WO1998023955A2 (de) 1998-06-04
ATE204082T1 (de) 2001-08-15
AR009638A1 (es) 2000-04-26
BR9714365A (pt) 2000-03-21

Similar Documents

Publication Publication Date Title
TW434405B (en) Process to determine antigen-specific antibodies of the immunoglobulin class M (IgM) and reagents used therein
US6645732B2 (en) Antigen-specific IgG detection
JPWO1994027150A1 (ja) 一種類以上の免疫学的配位子の分析方法,その分析試薬およびそのキット
JPH03502244A (ja) 試験方法およびそのための試薬キツト
JPH0814579B2 (ja) 特異的結合性物質の測定法及び試薬
EP2564188A1 (en) Assays for anti-drug antibodies in the presence of abundant endogenous protein counterpart of the drug
JP4130505B2 (ja) D−アミノ酸からなるペプチドによる診断方法の干渉の排除
CN101165491B (zh) 以金磁微粒为载体检测抗双链dna抗体的方法
JP7209498B2 (ja) B型肝炎ウイルスコア抗体の免疫測定方法
JPWO2009084369A1 (ja) Hiv−1抗原の検出用試薬及び検出方法
AU2016208414B2 (en) Method for detecting analyte, detection reagent kit, and detection reagent
FI100276B (fi) Menetelmä analyyttien ei-kilpailevaa määritystä varten
Ramesh Kumar et al. Sukumaran (2014) Anti-human IgG-horseradish peroxidase conjugate preparation and its use in ELISA and western blotting experiments
JPH04236353A (ja) 抗体の測定方法
KR940008091B1 (ko) 리간드의 면역학적 검출방법
CN101523216A (zh) 人类免疫缺陷病毒系列蛋白抗体测定方法
JP2003337134A (ja) 非特異反応抑制ペプチド、並びにこれを用いた非特異反応抑制方法及び抗体測定方法
JP3768165B2 (ja) 抗カルパスタチン抗体の測定法及び測定キット
US20050153383A1 (en) Synthetic and recombinant substrates for the detecion of the von willebrand factor-cleaving protease
JPH11512527A (ja) 検出用物質を形成する検出分子の混合物によるイムノアッセイ
EP1057034A1 (en) Assay for detection of phosphate or carbohydrate groups on serine residues
MXPA99004991A (es) Deteccion de antigenos especificos para la inmunoglobulina clase m
Copeland Immunological Methods
HK1258302A1 (zh) 用於测定fc区修饰的抗体的免疫测定法
MXPA99004995A (en) ANTIGEN-SPECIFIC IgG DETECTION